{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T15:56:13Z","timestamp":1788623773347,"version":"build-2803163510"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11882-025-01196-8","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T02:07:34Z","timestamp":1741918054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hyper IgE Syndrome: Bridging the Gap Between Immunodeficiency, Atopy, and Allergic Diseases"],"prefix":"10.1007","volume":"25","author":[{"given":"Henry","family":"Sutanto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galih Januar","family":"Adytia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deasy","family":"Fetarayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"key":"1196_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12016-009-8134-1","volume":"38","author":"J Heimall","year":"2010","unstructured":"Heimall J, Freeman A, Holland SM. Pathogenesis of Hyper IgE Syndrome. Clinic Rev Allerg Immunol. 2010;38:32\u20138. https:\/\/doi.org\/10.1007\/s12016-009-8134-1.","journal-title":"Clinic Rev Allerg Immunol"},{"key":"1196_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1601-0825.2008.01463.x","volume":"15","author":"A Freeman","year":"2009","unstructured":"Freeman A, Domingo D, Holland S. Hyper IgE (Job\u2019s) Syndrome: A Primary Immune Deficiency with Oral Manifestations. Oral Dis. 2009;15:2\u20137. https:\/\/doi.org\/10.1111\/j.1601-0825.2008.01463.x.","journal-title":"Oral Dis"},{"key":"1196_CR3","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJM199903043400904","volume":"340","author":"B Grimbacher","year":"1999","unstructured":"Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, Miller JA, O\u2019Connell AC, Puck JM. Hyper-IgE Syndrome with Recurrent Infections \u2014 An Autosomal Dominant Multisystem Disorder. N Engl J Med. 1999;340:692\u2013702. https:\/\/doi.org\/10.1056\/NEJM199903043400904.","journal-title":"N Engl J Med"},{"key":"1196_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.4103\/lungindia.lungindia_332_24","volume":"41","author":"NK Narahari","year":"2024","unstructured":"Narahari NK, Kodati R, Ranganath P, Kakarla B, Gongati P. Pulmonary Manifestations in Hyper IgE Syndrome: A Case Series and Review of Indian Literature. Lung India. 2024;41:464. https:\/\/doi.org\/10.4103\/lungindia.lungindia_332_24.","journal-title":"Lung India"},{"key":"1196_CR5","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJMoa073687","volume":"357","author":"SM Holland","year":"2007","unstructured":"Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, Freeman AF, Demidowich A, Davis J, Turner ML, et al. STAT3 Mutations in the Hyper-IgE Syndrome. N Engl J Med. 2007;357:1608\u201319. https:\/\/doi.org\/10.1056\/NEJMoa073687.","journal-title":"N Engl J Med"},{"key":"1196_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.iac.2008.01.005","volume":"28","author":"AF Freeman","year":"2008","unstructured":"Freeman AF, Holland SM. The Hyper-IgE Syndromes. Immunol Allergy Clin North Am. 2008;28:277\u201391. https:\/\/doi.org\/10.1016\/j.iac.2008.01.005.","journal-title":"Immunol Allergy Clin North Am"},{"key":"1196_CR7","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/nature06096","volume":"448","author":"Y Minegishi","year":"2007","unstructured":"Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, Kawamura N, Ariga T, Pasic S, Stojkovic O, et al. Dominant-Negative Mutations in the DNA-Binding Domain of STAT3 Cause Hyper-IgE Syndrome. Nature. 2007;448:1058\u201362. https:\/\/doi.org\/10.1038\/nature06096.","journal-title":"Nature"},{"key":"1196_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jaci.2008.04.037","volume":"122","author":"ED Renner","year":"2008","unstructured":"Renner ED, Rylaarsdam S, A\u0148over-Sombke S, Rack AL, Reichenbach J, Carey JC, Zhu Q, Jansson AF, Barboza J, Schimke LF, et al. Novel Signal Transducer and Activator of Transcription 3 (STAT3) Mutations, Reduced TH17 Cell Numbers, and Variably Defective STAT3 Phosphorylation in Hyper-IgE Syndrome. J Allergy Clin Immunol. 2008;122:181\u20137. https:\/\/doi.org\/10.1016\/j.jaci.2008.04.037.","journal-title":"J Allergy Clin Immunol"},{"key":"1196_CR9","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jaci.2009.10.038","volume":"124","author":"KR Engelhardt","year":"2009","unstructured":"Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, Chen A, Kim HS, Lloret MG, Schulze I, et al. Large Deletions and Point Mutations Involving the Dedicator of Cytokinesis 8 (DOCK8) in the Autosomal-Recessive Form of Hyper-IgE Syndrome. J Allergy Clin Immunol. 2009;124:1289-1302.e4. https:\/\/doi.org\/10.1016\/j.jaci.2009.10.038.","journal-title":"J Allergy Clin Immunol"},{"key":"1196_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-024-07180-w","volume":"15","author":"H Gu","year":"2024","unstructured":"Gu H, Xie M, Zhao S, Luo X, Huang Y, Yang L, Guan F, Lei J, Liu C. DOCK8 Gene Mutation Alters Cell Subsets, BCR Signaling, and Cell Metabolism in B Cells. Cell Death Dis. 2024;15:1\u201312. https:\/\/doi.org\/10.1038\/s41419-024-07180-w.","journal-title":"Cell Death Dis"},{"key":"1196_CR11","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/imcb.12209","volume":"97","author":"T Al-Shaikhly","year":"2019","unstructured":"Al-Shaikhly T, Ochs HD. Hyper IgE Syndromes: Clinical and Molecular Characteristics. Immunol Cell Biol. 2019;97:368\u201379. https:\/\/doi.org\/10.1111\/imcb.12209.","journal-title":"Immunol Cell Biol"},{"key":"1196_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.aller.2018.07.009","volume":"47","author":"S Alyasin","year":"2019","unstructured":"Alyasin S, Esmaeilzadeh H, Ebrahimi N, Nabavizadeh SH, Kashef S, Esmaeilzadeh E, Babaei M, Amin R. Phenotyping and Long-Term Follow up of Patients with Hyper IgE Syndrome. Allergol Immunopathol. 2019;47:152\u20138. https:\/\/doi.org\/10.1016\/j.aller.2018.07.009.","journal-title":"Allergol Immunopathol"},{"key":"1196_CR13","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.jaci.2014.02.025","volume":"133","author":"A Sassi","year":"2014","unstructured":"Sassi A, Lazaroski S, Wu G, Haslam SM, Fliegauf M, Mellouli F, Patiroglu T, Unal E, Ozdemir MA, Jouhadi Z, et al. Hypomorphic Homozygous Mutations in Phosphoglucomutase 3 (PGM3) Impair Immunity and Increase Serum IgE Levels. J Allergy Clin Immunol. 2014;133:1410-1419.e13. https:\/\/doi.org\/10.1016\/j.jaci.2014.02.025.","journal-title":"J Allergy Clin Immunol"},{"key":"1196_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/imr.12114","volume":"256","author":"DA Moulding","year":"2013","unstructured":"Moulding DA, Record J, Malinova D, Thrasher AJ. Actin Cytoskeletal Defects in Immunodeficiency. Immunol Rev. 2013;256:282\u201399. https:\/\/doi.org\/10.1111\/imr.12114.","journal-title":"Immunol Rev"},{"key":"1196_CR15","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.3390\/ijms24043391","volume":"24","author":"L Rusi\u00f1ol","year":"2023","unstructured":"Rusi\u00f1ol L, Puig L. Tyk2 Targeting in Immune-Mediated Inflammatory Diseases. Int J Mol Sci. 2023;24:3391. https:\/\/doi.org\/10.3390\/ijms24043391.","journal-title":"Int J Mol Sci"},{"key":"1196_CR16","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.immuni.2006.09.009","volume":"25","author":"Y Minegishi","year":"2006","unstructured":"Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, Takada H, Hara T, Kawamura N, Ariga T, et al. Human Tyrosine Kinase 2 Deficiency Reveals Its Requisite Roles in Multiple Cytokine Signals Involved in Innate and Acquired Immunity. Immunity. 2006;25:745\u201355. https:\/\/doi.org\/10.1016\/j.immuni.2006.09.009.","journal-title":"Immunity"},{"key":"1196_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.coi.2009.07.013","volume":"21","author":"Y Minegishi","year":"2009","unstructured":"Minegishi Y. Hyper-IgE Syndrome. Curr Opin Immunol. 2009;21:487\u201392. https:\/\/doi.org\/10.1016\/j.coi.2009.07.013.","journal-title":"Curr Opin Immunol"},{"key":"1196_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s10875-019-00713-5","volume":"40","author":"SA Sarrafzadeh","year":"2020","unstructured":"Sarrafzadeh SA, Mahloojirad M, Casanova J-L, Badalzadeh M, Bustamante J, Boisson-Dupuis S, Pourpak Z, Nourizadeh M, Moin M. A New Patient with Inherited TYK2 Deficiency. J Clin Immunol. 2020;40:232\u20135. https:\/\/doi.org\/10.1007\/s10875-019-00713-5.","journal-title":"J Clin Immunol"},{"key":"1196_CR19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nature06764","volume":"452","author":"JD Milner","year":"2008","unstructured":"Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, Kanno Y, Spalding C, Elloumi HZ, Paulson ML, et al. Impaired TH17 Cell Differentiation in Subjects with Autosomal Dominant Hyper-IgE Syndrome. Nature. 2008;452:773\u20136. https:\/\/doi.org\/10.1038\/nature06764.","journal-title":"Nature"},{"key":"1196_CR20","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1084\/jem.20080218","volume":"205","author":"CS Ma","year":"2008","unstructured":"Ma CS, Chew GYJ, Simpson N, Priyadarshi A, Wong M, Grimbacher B, Fulcher DA, Tangye SG, Cook MC. Deficiency of Th17 Cells in Hyper IgE Syndrome Due to Mutations in STAT3. J Exp Med. 2008;205:1551\u20137. https:\/\/doi.org\/10.1084\/jem.20080218.","journal-title":"J Exp Med"},{"key":"1196_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1749-6632.2011.06280.x","volume":"1246","author":"Y Minegishi","year":"2011","unstructured":"Minegishi Y, Saito M. Molecular Mechanisms of the Immunological Abnormalities in Hyper-IgE Syndrome. Ann N Y Acad Sci. 2011;1246:34\u201340. https:\/\/doi.org\/10.1111\/j.1749-6632.2011.06280.x.","journal-title":"Ann N Y Acad Sci"},{"key":"1196_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/WOX.0b013e31825a73b2","volume":"5","author":"EL Rael","year":"2012","unstructured":"Rael EL, Marshall RT, McClain JJ. The Hyper-IgE Syndromes: Lessons in Nature, From Bench to Bedside. World Allergy Organ J. 2012;5:79\u201387. https:\/\/doi.org\/10.1097\/WOX.0b013e31825a73b2.","journal-title":"World Allergy Organ J"},{"key":"1196_CR23","doi-asserted-by":"publisher","first-page":"100041","DOI":"10.1016\/j.mbm.2024.100041","volume":"2","author":"H Sutanto","year":"2024","unstructured":"Sutanto H. Mechanobiology of Type 1 Hypersensitivity: Elucidating the Impacts of Mechanical Forces in Allergic Reactions. Mechanobiol Med. 2024;2:100041. https:\/\/doi.org\/10.1016\/j.mbm.2024.100041.","journal-title":"Mechanobiol Med"},{"key":"1196_CR24","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.20061308","volume":"203","author":"SC Liang","year":"2006","unstructured":"Liang SC, Tan X-Y, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, Fouser LA. Interleukin (IL)-22 and IL-17 Are Coexpressed by Th17 Cells and Cooperatively Enhance Expression of Antimicrobial Peptides. J Exp Med. 2006;203:2271\u20139. https:\/\/doi.org\/10.1084\/jem.20061308.","journal-title":"J Exp Med"},{"key":"1196_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1586\/17476348.2014.854167","volume":"8","author":"ML Manni","year":"2014","unstructured":"Manni ML, Robinson KM, Alcorn JF. A Tale of Two Cytokines: IL-17 and IL-22 in Asthma and Infection. Expert Rev Respir Med. 2014;8:25\u201342. https:\/\/doi.org\/10.1586\/17476348.2014.854167.","journal-title":"Expert Rev Respir Med"},{"key":"1196_CR26","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.4049\/jimmunol.181.3.1767","volume":"181","author":"DT Avery","year":"2008","unstructured":"Avery DT, Bryant VL, Ma CS, de Waal Malefyt R, Tangye SG. IL-21-Induced Isotype Switching to IgG and IgA by Human Naive B Cells Is Differentially Regulated by IL-4. J Immunol. 2008;181:1767\u201379. https:\/\/doi.org\/10.4049\/jimmunol.181.3.1767.","journal-title":"J Immunol"},{"key":"1196_CR27","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/all.12416","volume":"69","author":"AC Boos","year":"2014","unstructured":"Boos AC, Hagl B, Schlesinger A, Halm BE, Ballenberger N, Pinarci M, Heinz V, Kreilinger D, Spielberger BD, Schimke-Marques LF, et al. Atopic Dermatitis, STAT3- and DOCK8-Hyper-IgE Syndromes Differ in IgE-Based Sensitization Pattern. Allergy. 2014;69:943\u201353. https:\/\/doi.org\/10.1111\/all.12416.","journal-title":"Allergy"},{"key":"1196_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2332\/allergolint.12-RAI-0423","volume":"61","author":"Y Minegishi","year":"2012","unstructured":"Minegishi Y, Saito M. Cutaneous Manifestations of Hyper IgE Syndrome. Allergol Int. 2012;61:191\u20136. https:\/\/doi.org\/10.2332\/allergolint.12-RAI-0423.","journal-title":"Allergol Int"},{"key":"1196_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000351912","volume":"6","author":"SP Smeekens","year":"2014","unstructured":"Smeekens SP, Huttenhower C, Riza A, van de Veerdonk FL, Zeeuwen PLJM, Schalkwijk J, van der Meer JWM, Xavier RJ, Netea MG, Gevers D. Skin Microbiome Imbalance in Patients with STAT1\/STAT3 Defects Impairs Innate Host Defense Responses. J Innate Immun. 2014;6:253\u201362. https:\/\/doi.org\/10.1159\/000351912.","journal-title":"J Innate Immun"},{"key":"1196_CR30","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/mi.2011.5","volume":"4","author":"HR Conti","year":"2011","unstructured":"Conti HR, Baker O, Freeman AF, Jang WS, Holland SM, Li RA, Edgerton M, Gaffen SL. New Mechanism of Oral Immunity to Mucosal Candidiasis in Hyper-IgE Syndrome. Mucosal Immunol. 2011;4:448\u201355. https:\/\/doi.org\/10.1038\/mi.2011.5.","journal-title":"Mucosal Immunol"},{"key":"1196_CR31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s13023-020-01516-3","volume":"15","author":"I Meixner","year":"2020","unstructured":"Meixner I, Hagl B, Kr\u00f6ner CI, Spielberger BD, Paschos E, D\u00fcckers G, Niehues T, Hesse R, Renner ED. Retained Primary Teeth in STAT3 Hyper-IgE Syndrome: Early Intervention in Childhood Is Essential. Orphanet J Rare Dis. 2020;15:244. https:\/\/doi.org\/10.1186\/s13023-020-01516-3.","journal-title":"Orphanet J Rare Dis"},{"key":"1196_CR32","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jaci.2010.06.029","volume":"126","author":"LF Schimke","year":"2010","unstructured":"Schimke LF, Sawalle-Belohradsky J, Roesler J, Wollenberg A, Rack A, Borte M, Rieber N, Cremer R, Maa\u00df E, Dopfer R, et al. Diagnostic Approach to the Hyper-IgE Syndromes: Immunologic and Clinical Key Findings to Differentiate Hyper-IgE Syndromes from Atopic Dermatitis. J Allergy Clin Immunol. 2010;126:611-617.e1. https:\/\/doi.org\/10.1016\/j.jaci.2010.06.029.","journal-title":"J Allergy Clin Immunol"},{"key":"1196_CR33","doi-asserted-by":"publisher","first-page":"e2020100118","DOI":"10.1073\/pnas.2020100118","volume":"118","author":"PS Yadav","year":"2021","unstructured":"Yadav PS, Feng S, Cong Q, Kim H, Liu Y, Yang Y. Stat3 Loss in Mesenchymal Progenitors Causes Job Syndrome\u2013like Skeletal Defects by Reducing Wnt\/\u03b2-Catenin Signaling. Proc Natl Acad Sci. 2021;118:e2020100118. https:\/\/doi.org\/10.1073\/pnas.2020100118.","journal-title":"Proc Natl Acad Sci"},{"key":"1196_CR34","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.molimm.2010.01.010","volume":"47","author":"AD Papanastasiou","year":"2010","unstructured":"Papanastasiou AD, Mantagos S, Papanastasiou DA, Zarkadis IK. A Novel Mutation in the Signal Transducer and Activator of Transcription 3 (STAT3) Gene, in Hyper-IgE Syndrome. Mol Immunol. 2010;47:1629\u201334. https:\/\/doi.org\/10.1016\/j.molimm.2010.01.010.","journal-title":"Mol Immunol"},{"key":"1196_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10875-014-0126-0","volume":"35","author":"SE Aydin","year":"2015","unstructured":"Aydin SE, Kilic SS, Aytekin C, Kumar A, Porras O, Kainulainen L, Kostyuchenko L, Genel F, K\u00fct\u00fckc\u00fcler N, Karaca N, et al. DOCK8 Deficiency: Clinical and Immunological Phenotype and Treatment Options - a Review of 136 Patients. J Clin Immunol. 2015;35:189\u201398. https:\/\/doi.org\/10.1007\/s10875-014-0126-0.","journal-title":"J Clin Immunol"},{"key":"1196_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fped.2017.00038","volume":"5","author":"VR Dimitriades","year":"2017","unstructured":"Dimitriades VR, Devlin V, Pittaluga S, Su HC, Holland SM, Wilson W, Dunleavy K, Shah NN, Freeman AF. DOCK 8 Deficiency, EBV+ Lymphomatoid Granulomatosis, and Intrafamilial Variation in Presentation. Front Pediatr. 2017;5:38. https:\/\/doi.org\/10.3389\/fped.2017.00038.","journal-title":"Front Pediatr"},{"key":"1196_CR37","doi-asserted-by":"publisher","first-page":"e14073","DOI":"10.1111\/pai.14073","volume":"35","author":"E Liquidano-Perez","year":"2024","unstructured":"Liquidano-Perez E, Maza-Ramos G, Perez Arias BA, Lugo Reyes SO, Barragan Arevalo T, Solorzano-Morales SA, Venegas Montoya E, Staines-Boone AT, Guzm\u00e1n Cotaya R, Okada S, et al. Clinical, Immunological, and Genetic Description of a Mexican Cohort of Patients with DOCK8 Deficiency. Pediatric Allergy Immunol. 2024;35:e14073. https:\/\/doi.org\/10.1111\/pai.14073.","journal-title":"Pediatric Allergy Immunol"},{"key":"1196_CR38","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/all.13610","volume":"74","author":"M Jacob","year":"2019","unstructured":"Jacob M, Bin Khalaf D, Alhissi S, Arnout R, Alsaud B, Al-Mousa H, Lopata AL, Alazami AM, Dasouki M, Abdel Rahman AM. Quantitative Profiling of Cytokines and Chemokines in DOCK8-Deficient and Atopic Dermatitis Patients. Allergy. 2019;74:370\u20139. https:\/\/doi.org\/10.1111\/all.13610.","journal-title":"Allergy"},{"key":"1196_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/archdermatol.2011.262","volume":"148","author":"EY Chu","year":"2012","unstructured":"Chu EY, Freeman AF, Jing H, Cowen EW, Davis J, Su HC, Holland SM, Chanco Turner ML. Cutaneous Manifestations of DOCK8 Deficiency Syndrome. Arch Dermatol. 2012;148:79\u201384. https:\/\/doi.org\/10.1001\/archdermatol.2011.262.","journal-title":"Arch Dermatol"},{"key":"1196_CR40","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ajhg.2014.05.007","volume":"95","author":"A Stray-Pedersen","year":"2014","unstructured":"Stray-Pedersen A, Backe PH, Sorte HS, M\u00f8rkrid L, Chokshi NY, Erichsen HC, Gambin T, Elgst\u00f8en KBP, Bj\u00f8r\u00e5s M, Wlodarski MW, et al. PGM3 Mutations Cause a Congenital Disorder of Glycosylation with Severe Immunodeficiency and Skeletal Dysplasia. Am J Hum Genet. 2014;95:96\u2013107. https:\/\/doi.org\/10.1016\/j.ajhg.2014.05.007.","journal-title":"Am J Hum Genet"},{"key":"1196_CR41","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.jaci.2014.02.013","volume":"133","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Yu X, Ichikawa M, Lyons JJ, Datta S, Lamborn IT, Jing H, Kim ES, Biancalana M, Wolfe LA, et al. Autosomal Recessive Phosphoglucomutase 3 (PGM3) Mutations Link Glycosylation Defects to Atopy, Immune Deficiency, Autoimmunity, and Neurocognitive Impairment. J Allergy Clin Immunol. 2014;133:1400-1409.e5. https:\/\/doi.org\/10.1016\/j.jaci.2014.02.013.","journal-title":"J Allergy Clin Immunol"},{"key":"1196_CR42","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/j.jaci.2009.11.017","volume":"125","author":"KD Stone","year":"2010","unstructured":"Stone KD, Prussin C, Metcalfe DD. IgE, Mast Cells, Basophils, and Eosinophils. J Allergy Clin Immunol. 2010;125:S73\u201380. https:\/\/doi.org\/10.1016\/j.jaci.2009.11.017.","journal-title":"J Allergy Clin Immunol"},{"key":"1196_CR43","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nm.2755","volume":"18","author":"SJ Galli","year":"2012","unstructured":"Galli SJ, Tsai M. IgE and Mast Cells in Allergic Disease. Nat Med. 2012;18:693\u2013704. https:\/\/doi.org\/10.1038\/nm.2755.","journal-title":"Nat Med"},{"key":"1196_CR44","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jaci.2013.08.045","volume":"132","author":"AM Siegel","year":"2013","unstructured":"Siegel AM, Stone KD, Cruse G, Lawrence MG, Olivera A, Jung M, Barber JS, Freeman AF, Holland SM, O\u2019Brien M, et al. Diminished Allergic Disease in Patients with STAT3 Mutations Reveals a Role for STAT3 Signaling in Mast Cell Degranulation. J Allergy Clin Immunol. 2013;132:1388-1396.e3. https:\/\/doi.org\/10.1016\/j.jaci.2013.08.045.","journal-title":"J Allergy Clin Immunol"},{"key":"1196_CR45","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.alit.2021.07.007","volume":"70","author":"Y Minegishi","year":"2021","unstructured":"Minegishi Y. Hyper-IgE Syndrome, 2021 Update. Allergol Int. 2021;70:407\u201314. https:\/\/doi.org\/10.1016\/j.alit.2021.07.007.","journal-title":"Allergol Int"},{"key":"1196_CR46","doi-asserted-by":"crossref","unstructured":"Seghezzo, S.; Dorsey, M. Rash and Several Food Allergies. In Pediatric Immunology: A Case-Based Collection with MCQs, Volume 2; Rezaei, N., Ed.; Springer International Publishing: Cham, 2019; pp. 233\u2013236","DOI":"10.1007\/978-3-030-21262-9_45"},{"key":"1196_CR47","doi-asserted-by":"publisher","first-page":"604725","DOI":"10.3389\/fped.2020.604725","volume":"8","author":"JCMM Villanueva","year":"2020","unstructured":"Villanueva JCMM, Chan K-W, Ong RC, Andaya AG, Lau Y-L, van Zelm MC, Kanegane H. Hyper IgE Syndrome Associated With Warts: A First Case of Dedicator of Cytokinesis 8 Deficiency in the Philippines. Front Pediatr. 2020;8:604725. https:\/\/doi.org\/10.3389\/fped.2020.604725.","journal-title":"Front Pediatr"},{"key":"1196_CR48","doi-asserted-by":"publisher","first-page":"e0215","DOI":"10.1097\/MD.0000000000010215","volume":"97","author":"H Fan","year":"2018","unstructured":"Fan H, Huang L, Yang D, Lin Y, Lu G, Xie Y, Yu J, Zhang D. Pediatric Hyperimmunoglobulin E Syndrome. Medicine. 2018;97:e0215. https:\/\/doi.org\/10.1097\/MD.0000000000010215.","journal-title":"Medicine"},{"key":"1196_CR49","doi-asserted-by":"publisher","first-page":"102452","DOI":"10.1016\/j.amsu.2021.102452","volume":"66","author":"N Bhutani","year":"2021","unstructured":"Bhutani N, Sharma U, Kumar A, Kajal P. Pediatric Hyperimmunoglobulin E Syndrome (Job\u2019s Syndrome) with STAT3 Mutation: A Case Report. Ann Med Surg. 2021;66:102452. https:\/\/doi.org\/10.1016\/j.amsu.2021.102452.","journal-title":"Ann Med Surg"},{"key":"1196_CR50","first-page":"108","volume":"42","author":"J-H Cho","year":"2004","unstructured":"Cho J-H, Kim M-Y, Park Y-M, Kim H-O. A Case of Hyper-IgE Syndrome Presenting as a Vesiculopustular Eruption in an Infant. Korean J Dermatol. 2004;42:108\u201310.","journal-title":"Korean J Dermatol"},{"key":"1196_CR51","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/S0091-6749(96)80202-8","volume":"98","author":"K Desai","year":"1996","unstructured":"Desai K, Huston DP, Harriman GR. Previously Undiagnosed Hyper-IgE Syndrome in an Adult with Multiple Systemic Fungal Infections. J Allergy Clin Immunol. 1996;98:1123\u20134. https:\/\/doi.org\/10.1016\/S0091-6749(96)80202-8.","journal-title":"J Allergy Clin Immunol"},{"key":"1196_CR52","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1182\/blood.V130.Suppl_1.4825.4825","volume":"130","author":"D Hansra","year":"2017","unstructured":"Hansra D, Cioffi-Lavina M, Granada H, McIntyre B, Patrick C, Keniff S. Rare Case of Adult Onset DOCK8 Mutated Hyper Ige Syndrome. Blood. 2017;130:4825. https:\/\/doi.org\/10.1182\/blood.V130.Suppl_1.4825.4825.","journal-title":"Blood"},{"key":"1196_CR53","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1016\/j.jaci.2003.12.430","volume":"113","author":"H Tcheurekdjian","year":"2004","unstructured":"Tcheurekdjian H, Hostoffer RW. Hyper-IgE Syndrome, or Not. J Allergy Clin Immunol. 2004;113:S122. https:\/\/doi.org\/10.1016\/j.jaci.2003.12.430.","journal-title":"J Allergy Clin Immunol"},{"key":"1196_CR54","doi-asserted-by":"publisher","first-page":"1057679","DOI":"10.3389\/fimmu.2022.1057679","volume":"13","author":"R Yaakoubi","year":"2023","unstructured":"Yaakoubi R, Mekki N, Ben-Mustapha I, Ben-Khemis L, Bouaziz A, Ben Fraj I, Ammar J, Hamzaoui A, Turki H, Boussofara L, et al. Diagnostic Challenge in a Series of Eleven Patients with Hyper IgE Syndromes. Front Immunol. 2023;13:1057679. https:\/\/doi.org\/10.3389\/fimmu.2022.1057679.","journal-title":"Front Immunol"},{"key":"1196_CR55","doi-asserted-by":"publisher","first-page":"626593","DOI":"10.3389\/fimmu.2021.626593","volume":"12","author":"B Saikia","year":"2021","unstructured":"Saikia B, Rawat A, Minz RW, Suri D, Pandiarajan V, Jindal A, Sahu S, Karim A, Desai M, Taur PD, et al. Clinical Profile of Hyper-IgE Syndrome in India. Front Immunol. 2021;12:626593. https:\/\/doi.org\/10.3389\/fimmu.2021.626593.","journal-title":"Front Immunol"},{"key":"1196_CR56","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s12098-016-2150-y","volume":"83","author":"S Sharma","year":"2016","unstructured":"Sharma S, Saikia B, Goel S, Rawat A, Minz RW, Suri D, Chhabra S, Singh S. TH17 Cells in STAT3 Related Hyper-IgE Syndrome. Indian J Pediatr. 2016;83:1104\u20138. https:\/\/doi.org\/10.1007\/s12098-016-2150-y.","journal-title":"Indian J Pediatr"},{"key":"1196_CR57","doi-asserted-by":"publisher","first-page":"102149","DOI":"10.1016\/j.rmcr.2024.102149","volume":"53","author":"J Nordin","year":"2025","unstructured":"Nordin J, Smetana S, Johnson R, Bartosiak A, Nassif N. Break through the Mold: Hyper-IgE Syndrome as a Vehicle for Invasive Aspergillosis. Respir Med Case Rep. 2025;53:102149. https:\/\/doi.org\/10.1016\/j.rmcr.2024.102149.","journal-title":"Respir Med Case Rep"},{"key":"1196_CR58","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s001060050492","volume":"47","author":"F Waldfahrer","year":"1999","unstructured":"Waldfahrer F, Pahl S, Federspil PA, Iro H. Das Hyper-IgE-Syndrom mit HNO-Manifestationen\u00dcbersicht und Fallbericht \u00fcber eine erfolgreiche Therapie mit hochdosiertem i.v.-Immunglobulin. HNO. 1999;47:1063\u20138. https:\/\/doi.org\/10.1007\/s001060050492.","journal-title":"HNO"},{"key":"1196_CR59","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/ar4069","volume":"14","author":"PF Yong","year":"2012","unstructured":"Yong PF, Freeman AF, Engelhardt KR, Holland S, Puck JM, Grimbacher B. An Update on the Hyper-IgE Syndromes. Arthritis Res Ther. 2012;14:228. https:\/\/doi.org\/10.1186\/ar4069.","journal-title":"Arthritis Res Ther"},{"key":"1196_CR60","doi-asserted-by":"crossref","unstructured":"Matterne, U.; B\u00f6hmer, M.M.; Weisshaar, E.; Jupiter, A.; Carter, B.; Apfelbacher, C.J. 2019 Oral H1 Antihistamines as \u2018Add\u2010on\u2019 Therapy to Topical Treatment for Eczema. Cochrane Library","DOI":"10.1002\/14651858.CD012167.pub2"},{"key":"1196_CR61","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.1016\/j.anai.2024.08.787","volume":"133","author":"N Patel","year":"2024","unstructured":"Patel N, Langford J, Gohsman Z. UTILIZING DUPILUMAB IN TREATMENT OF ATOPIC DERMATITIS IN A PEDIATRIC PATIENT WITH HYPER-IGE SYNDROME. Ann Allergy Asthma Immunol. 2024;133:S207. https:\/\/doi.org\/10.1016\/j.anai.2024.08.787.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1196_CR62","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1517\/14712598.3.2.371","volume":"3","author":"G D\u2019Amato","year":"2003","unstructured":"D\u2019Amato G. Therapy of Allergic Bronchial Asthma with Omalizumab - an Anti-IgE Monoclonal Antibody. Expert Opin Biol Ther. 2003;3:371\u20136.","journal-title":"Expert Opin Biol Ther"},{"key":"1196_CR63","doi-asserted-by":"publisher","first-page":"835257","DOI":"10.3389\/fmed.2022.835257","volume":"9","author":"J Lan","year":"2022","unstructured":"Lan J, Zhang Y, Song M, Cai S, Luo H, OuYang R, Yang P, Shi X, Long Y, Chen Y. Omalizumab for STAT3 Hyper-IgE Syndromes in Adulthood: A Case Report and Literature Review. Front Med. 2022;9:835257. https:\/\/doi.org\/10.3389\/fmed.2022.835257.","journal-title":"Front Med"},{"key":"1196_CR64","doi-asserted-by":"publisher","unstructured":"Nsour, R.; Alkhatib, A.; Shannak, R.; Daoud, A. 2023 The Effectiveness of Omalizumab in the Treatment of Hyper-IgE Syndrome: A Case Report. JAP Acad J 1, https:\/\/doi.org\/10.58877\/japaj.v1i3.61.","DOI":"10.58877\/japaj.v1i3.61"},{"key":"1196_CR65","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/cia2.12273","volume":"5","author":"KH Nguyen","year":"2022","unstructured":"Nguyen KH, Nguyen QA, Tran MH, Can TT, Vu MT, Vo NS, Chi HC, van Nunen S, Van Nguyen D. Autosomal Recessive Hyper-IgE Syndrome Due to DOCK8 Deficiency: An Adjunctive Role for Omalizumab. J Cutaneous Immunol Allergy. 2022;5:222\u20136. https:\/\/doi.org\/10.1002\/cia2.12273.","journal-title":"J Cutaneous Immunol Allergy"},{"key":"1196_CR66","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","volume":"375","author":"EL Simpson","year":"2016","unstructured":"Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour J-P, et al. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. N Engl J Med. 2016;375:2335\u201348. https:\/\/doi.org\/10.1056\/NEJMoa1610020.","journal-title":"N Engl J Med"},{"key":"1196_CR67","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s10875-020-00751-4","volume":"40","author":"R L\u00e9vy","year":"2020","unstructured":"L\u00e9vy R, B\u00e9ziat V, Barbieux C, Puel A, Bourrat E, Casanova J-L, Hovnanian A. Efficacy of Dupilumab for Controlling Severe Atopic Dermatitis in a Patient with Hyper-IgE Syndrome. J Clin Immunol. 2020;40:418\u201320. https:\/\/doi.org\/10.1007\/s10875-020-00751-4.","journal-title":"J Clin Immunol"},{"key":"1196_CR68","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.1016\/j.anai.2022.08.912","volume":"129","author":"M Anderson","year":"2022","unstructured":"Anderson M, Newell B, Escobar H, Stahl E, Raje N. A CASE OF DOCK8 DEFICIENCY TREATED WITH DUPILUMAB. Ann Allergy Asthma Immunol. 2022;129:S141. https:\/\/doi.org\/10.1016\/j.anai.2022.08.912.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1196_CR69","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/eji.201242605","volume":"42","author":"S Cypowyj","year":"2012","unstructured":"Cypowyj S, Picard C, Mar\u00f3di L, Casanova J-L, Puel A. Immunity to Infection in IL-17-Deficient Mice and Humans. Eur J Immunol. 2012;42:2246\u201354. https:\/\/doi.org\/10.1002\/eji.201242605.","journal-title":"Eur J Immunol"},{"key":"1196_CR70","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1080\/2314808X.2023.2253601","volume":"10","author":"RE El-Hennamy","year":"2023","unstructured":"El-Hennamy RE, El-Shorbagy AA, Elbeltagy RS, Shafaa MW, Nady S. Response to Treatment of Murine Schistosomiasis with Recombinant IL-22 under Different Circadian Timing. Egypt J Basic Appl Sci. 2023;10:697\u2013710. https:\/\/doi.org\/10.1080\/2314808X.2023.2253601.","journal-title":"Egypt J Basic Appl Sci"},{"key":"1196_CR71","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0001-7310(14)70016-X","volume":"105","author":"Y Ling","year":"2014","unstructured":"Ling Y, Puel A. IL-17 and Infections. Actas Dermosifiliogr. 2014;105:34\u201340. https:\/\/doi.org\/10.1016\/S0001-7310(14)70016-X.","journal-title":"Actas Dermosifiliogr"},{"key":"1196_CR72","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1080\/21645515.2018.1461300","volume":"14","author":"A Markota","year":"2018","unstructured":"Markota A, Endres S, Kobold S. Targeting Interleukin-22 for Cancer Therapy. Hum Vaccin Immunother. 2018;14:2012\u20135. https:\/\/doi.org\/10.1080\/21645515.2018.1461300.","journal-title":"Hum Vaccin Immunother"},{"key":"1196_CR73","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1600-065X.2008.00644.x","volume":"223","author":"M Pesu","year":"2008","unstructured":"Pesu M, Laurence A, Kishore N, Zwillich SH, Chan G, O\u2019Shea JJ. Therapeutic Targeting of Janus Kinases. Immunol Rev. 2008;223:132\u201342. https:\/\/doi.org\/10.1111\/j.1600-065X.2008.00644.x.","journal-title":"Immunol Rev"},{"key":"1196_CR74","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nrd.2017.201","volume":"16","author":"DM Schwartz","year":"2017","unstructured":"Schwartz DM, Kanno Y, Villarino A, Ward M, Gadina M, O\u2019Shea JJ. JAK Inhibition as a Therapeutic Strategy for Immune and Inflammatory Diseases. Nat Rev Drug Discov. 2017;16:843\u201362. https:\/\/doi.org\/10.1038\/nrd.2017.201.","journal-title":"Nat Rev Drug Discov"},{"key":"1196_CR75","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s10875-022-01273-x","volume":"42","author":"PB Lobo","year":"2022","unstructured":"Lobo PB, Guisado-Hern\u00e1ndez P, Villaoslada I, de Felipe B, Carreras C, Rodriguez H, Carazo-Gallego B, M\u00e9ndez-Echevarria A, Lucena JM, Aljaro PO, et al. Ex Vivo Effect of JAK Inhibition on JAK-STAT1 Pathway Hyperactivation in Patients with Dominant-Negative STAT3 Mutations. J Clin Immunol. 2022;42:1193\u2013204. https:\/\/doi.org\/10.1007\/s10875-022-01273-x.","journal-title":"J Clin Immunol"},{"key":"1196_CR76","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1182\/blood-2016-02-700013","volume":"128","author":"S Maschalidi","year":"2016","unstructured":"Maschalidi S, Sepulveda FE, Garrigue A, Fischer A, de Saint Basile G. Therapeutic Effect of JAK1\/2 Blockade on the Manifestations of Hemophagocytic Lymphohistiocytosis in Mice. Blood. 2016;128:60\u201371. https:\/\/doi.org\/10.1182\/blood-2016-02-700013.","journal-title":"Blood"},{"key":"1196_CR77","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1007\/s10875-021-00971-2","volume":"41","author":"SC Harrison","year":"2021","unstructured":"Harrison SC, Tsilifis C, Slatter MA, Nademi Z, Worth A, Veys P, Ponsford MJ, Jolles S, Al-Herz W, Flood T, et al. Hematopoietic Stem Cell Transplantation Resolves the Immune Deficit Associated with STAT3-Dominant-Negative Hyper-IgE Syndrome. J Clin Immunol. 2021;41:934\u201343. https:\/\/doi.org\/10.1007\/s10875-021-00971-2.","journal-title":"J Clin Immunol"},{"key":"1196_CR78","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10875-015-0167-z","volume":"35","author":"NC Patel","year":"2015","unstructured":"Patel NC, Gallagher JL, Torgerson TR, Gilman AL. Successful Haploidentical Donor Hematopoietic Stem Cell Transplant and Restoration of STAT3 Function in an Adolescent with Autosomal Dominant Hyper-IgE Syndrome. J Clin Immunol. 2015;35:479\u201385. https:\/\/doi.org\/10.1007\/s10875-015-0167-z.","journal-title":"J Clin Immunol"},{"key":"1196_CR79","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10875-016-0278-1","volume":"36","author":"M Yanagimachi","year":"2016","unstructured":"Yanagimachi M, Ohya T, Yokosuka T, Kajiwara R, Tanaka F, Goto H, Takashima T, Morio T, Yokota S. The Potential and Limits of Hematopoietic Stem Cell Transplantation for the Treatment of Autosomal Dominant Hyper-IgE Syndrome. J Clin Immunol. 2016;36:511\u20136. https:\/\/doi.org\/10.1007\/s10875-016-0278-1.","journal-title":"J Clin Immunol"},{"key":"1196_CR80","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejphar.2015.05.071","volume":"778","author":"T Zhang","year":"2016","unstructured":"Zhang T, Finn DF, Barlow JW, Walsh JJ. Mast Cell Stabilisers. Eur J Pharmacol. 2016;778:158\u201368. https:\/\/doi.org\/10.1016\/j.ejphar.2015.05.071.","journal-title":"Eur J Pharmacol"},{"key":"1196_CR81","doi-asserted-by":"publisher","first-page":"793010","DOI":"10.3389\/fgeed.2022.793010","volume":"4","author":"S Ravendran","year":"2022","unstructured":"Ravendran S, Hern\u00e1ndez SS, K\u00f6nig S, Bak RO. CRISPR\/Cas-Based Gene Editing Strategies for DOCK8 Immunodeficiency Syndrome. Front Genome Ed. 2022;4:793010. https:\/\/doi.org\/10.3389\/fgeed.2022.793010.","journal-title":"Front Genome Ed"},{"key":"1196_CR82","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1089\/crispr.2020.0111","volume":"4","author":"AC Eberherr","year":"2021","unstructured":"Eberherr AC, Maaske A, Wolf C, Giesert F, Berutti R, Rusha E, Pertek A, Kastlmeier MT, Voss C, Plummer M, et al. Rescue of STAT3 Function in Hyper-IgE Syndrome Using Adenine Base Editing. CRISPR J. 2021;4:178\u201390. https:\/\/doi.org\/10.1089\/crispr.2020.0111.","journal-title":"CRISPR J"},{"key":"1196_CR83","doi-asserted-by":"publisher","unstructured":"Sutanto, H.; Elisa, E.; Rachma, B.; Fetarayani, D. Gut Microbiome Modulation in Allergy Treatment: The Role of Fecal Microbiota Transplantation. Am J Med 2025 https:\/\/doi.org\/10.1016\/j.amjmed.2025.01.005.","DOI":"10.1016\/j.amjmed.2025.01.005"},{"key":"1196_CR84","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3390\/pathogens12040518","volume":"12","author":"M Sharma","year":"2023","unstructured":"Sharma M, Dhaliwal M, Tyagi R, Goyal T, Sharma S, Rawat A. Microbiome and Its Dysbiosis in Inborn Errors of Immunity. Pathogens. 2023;12:518. https:\/\/doi.org\/10.3390\/pathogens12040518.","journal-title":"Pathogens"},{"key":"1196_CR85","doi-asserted-by":"publisher","first-page":"15654","DOI":"10.3390\/ijms242115654","volume":"24","author":"Z Han","year":"2023","unstructured":"Han Z, Min Y, Pang K, Wu D. Therapeutic Approach Targeting Gut Microbiome in Gastrointestinal Infectious Diseases. IJMS. 2023;24:15654. https:\/\/doi.org\/10.3390\/ijms242115654.","journal-title":"IJMS"},{"key":"1196_CR86","doi-asserted-by":"publisher","first-page":"4925","DOI":"10.1038\/s41388-020-1341-1","volume":"39","author":"W Fong","year":"2020","unstructured":"Fong W, Li Q, Yu J. Gut Microbiota Modulation: A Novel Strategy for Prevention and Treatment of Colorectal Cancer. Oncogene. 2020;39:4925\u201343. https:\/\/doi.org\/10.1038\/s41388-020-1341-1.","journal-title":"Oncogene"},{"key":"1196_CR87","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s10875-013-9932-z","volume":"33","author":"S Martin","year":"2013","unstructured":"Martin S, Wolters P, Billings N, Toledo-Tamula MA, Hammoud DA, Welch P, Darnell D, Holland SM, Freeman AF. Neurobehavioral Profiles in Individuals with Hyperimmunoglobulin E Syndrome (HIES) and Brain White Matter Hyperintensities. J Clin Immunol. 2013;33:1175\u201384. https:\/\/doi.org\/10.1007\/s10875-013-9932-z.","journal-title":"J Clin Immunol"},{"key":"1196_CR88","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1586\/1744666X.1.4.645","volume":"1","author":"AF Freeman","year":"2005","unstructured":"Freeman AF, Holland SM. Hyper IgE Syndrome: Review and Future Directions. Expert Rev Clin Immunol. 2005;1:645\u201351. https:\/\/doi.org\/10.1586\/1744666X.1.4.645.","journal-title":"Expert Rev Clin Immunol"},{"key":"1196_CR89","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/2229-5178.126038","volume":"5","author":"Y Dang","year":"2014","unstructured":"Dang Y, Ren J, Guo Y, Geng S. Hyper IgE Syndrome. Indian Dermatol Online J. 2014;5:69. https:\/\/doi.org\/10.4103\/2229-5178.126038.","journal-title":"Indian Dermatol Online J"},{"key":"1196_CR90","doi-asserted-by":"publisher","unstructured":"Renner E, Belohradsky B, Grimbacher B. Hyper-IgE-Syndrome AL. 2004;27:408\u201314. https:\/\/doi.org\/10.5414\/ALP27408.","DOI":"10.5414\/ALP27408"},{"key":"1196_CR91","doi-asserted-by":"publisher","first-page":"200","DOI":"10.5603\/ARM.27992","volume":"75","author":"U Nowicka","year":"2007","unstructured":"Nowicka U, Wiatr E, Kupis W, Burakowska B, Folcik K, Or\u0142owski T, Roszkowski-\u015ali\u017c K. Pneumatocele w Trakcie D\u0142ugotrwa\u0142ej Obserwacji Chorego Na Zesp\u00f3\u0142 Hiper IgE (Zesp\u00f3\u0142 Hioba). Adv Respir Med. 2007;75:200\u20137. https:\/\/doi.org\/10.5603\/ARM.27992.","journal-title":"Adv Respir Med"},{"key":"1196_CR92","doi-asserted-by":"publisher","first-page":"168","DOI":"10.24287\/1726-1708-2024-23-2-168-173","volume":"23","author":"AA Bazaev","year":"2024","unstructured":"Bazaev AA, Kozlovskaya SN, Vasilyeva AP, Skvortsova YuV, Balashov DN. A Case of Allogeneic Hematopoietic Stem Cell Transplantation in a Patient with Hyper-IgE Syndrome. Voprosy gematologii\/onkologii i immunopatologii v pediatrii. 2024;23:168\u201373. https:\/\/doi.org\/10.24287\/1726-1708-2024-23-2-168-173.","journal-title":"Voprosy gematologii\/onkologii i immunopatologii v pediatrii"},{"key":"1196_CR93","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4103\/jms.jms_23_17","volume":"32","author":"N Thokchom","year":"2018","unstructured":"Thokchom N, Verma K, Sangma K, Bishurul Hafi N. Hyper-IgE Syndrome. J Med Soc. 2018;32:154. https:\/\/doi.org\/10.4103\/jms.jms_23_17.","journal-title":"J Med Soc"},{"key":"1196_CR94","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1055\/s-0030-1265135","volume":"222","author":"TC Bittner","year":"2010","unstructured":"Bittner TC, Pannicke U, Renner ED, Notheis G, Hoffmann F, Belohradsky BH, Wintergerst U, Hauser M, Klein B, Schwarz K, et al. Successful Long-Term Correction of Autosomal Recessive Hyper-IgE Syndrome due to DOCK8 Deficiency by Hematopoietic Stem Cell Transplantation. Klin Padiatr. 2010;222:351\u20135. https:\/\/doi.org\/10.1055\/s-0030-1265135.","journal-title":"Klin Padiatr"},{"key":"1196_CR95","doi-asserted-by":"crossref","unstructured":"Al-Shaikhly, T. Hyper IgE Syndrome. In Primary and Secondary Immunodeficiency; Bernstein, J.A., Ed.; Springer International Publishing: Cham, 2021; pp. 149\u2013167","DOI":"10.1007\/978-3-030-57157-3_10"},{"key":"1196_CR96","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2174\/1573396320666230912103124","volume":"20","author":"S Gracci","year":"2024","unstructured":"Gracci S, Novelli T, D\u2019Elios S, Bernardini R, Peroni D. Hyper IgE Syndromes. Curr Pediatr Rev. 2024;20:253\u201364. https:\/\/doi.org\/10.2174\/1573396320666230912103124.","journal-title":"Curr Pediatr Rev"},{"key":"1196_CR97","doi-asserted-by":"publisher","first-page":"AB111","DOI":"10.1016\/j.jaci.2018.12.337","volume":"143","author":"MR Goncalves","year":"2019","unstructured":"Goncalves MR, Junior PR. Association between STAT3 Mutations and Phenotypic Features in Hyper-IgE Syndrome. J Allergy Clin Immunol. 2019;143:AB111. https:\/\/doi.org\/10.1016\/j.jaci.2018.12.337.","journal-title":"J Allergy Clin Immunol"},{"key":"1196_CR98","doi-asserted-by":"publisher","first-page":"5582","DOI":"10.1097\/MS9.0000000000002407","volume":"86","author":"P Adhikari","year":"2024","unstructured":"Adhikari P, Regmi R, Yadav PS, Kafle S. Challenges in Diagnosing and Managing Hyper-IgE Syndrome in a Resource-Limited Setting: A Case Report. Ann Med Surg. 2024;86:5582\u20135. https:\/\/doi.org\/10.1097\/MS9.0000000000002407.","journal-title":"Ann Med Surg"},{"key":"1196_CR99","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2310\/6620.2007.06025","volume":"18","author":"DJ Hijnen","year":"2007","unstructured":"Hijnen DJ, Knol E, Bruijnzeel-Koomen C, de Bruin-Weller M. Cyclosporin A Treatment Is Associated with Increased Serum Immunoglobulin E Levels in a Subgroup of Atopic Dermatitis Patients. Dermatitis. 2007;18:163\u20135. https:\/\/doi.org\/10.2310\/6620.2007.06025.","journal-title":"Dermatitis"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-025-01196-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-025-01196-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-025-01196-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T13:57:07Z","timestamp":1741960627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-025-01196-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1196"],"URL":"https:\/\/doi.org\/10.1007\/s11882-025-01196-8","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"19 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"17"}}